H. Fennema

发表

Generalized Expected Utility Theory : the Rank Dependent Model - John Quiggin

H. Fennema, T. Bezembinder, 1995 .

A test of rank-dependent utility in the context of ambiguity

H. Fennema, P. Wakker, 1996 .

Spectral Tuning, Fluorescence, and Photoactivity in Hybrids of Photoactive Yellow Protein, Reconstituted with Native or Modified Chromophores*

H. Fennema, K. Hellingwerf, J. Verhoeven, 1996, The Journal of Biological Chemistry.

Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers

R. Peters, H. Fennema, H. Büller, 2002, Circulation.

Chapterr 1 0 RECOMBINANTT FACTOR VIIA REVERSES THE ANTICOAGULANT EFFECTT OF THE LONG-ACTING PENTASACCHARIDE IDRAPARINUX INN HEALTHY VOLUNTEERS

R. Peters, H. Fennema, H. Büller, 2008 .

Recombinant factor VIIa reverses the anticoagulant effect of the long‐acting pentasaccharide idraparinux in healthy volunteers

R. Peters, H. Fennema, H. Büller, 2004, British journal of haematology.

Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers

R. Peters, H. Fennema, H. Büller, 2003 .

Use of Sugammadex in Patients With Obesity: A Pooled Analysis

H. Fennema, T. Monk, H. Rietbergen, 2017, American journal of therapeutics.

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

H. Fennema, H. Schuitemaker, J. Stoddard, 2021, The New England journal of medicine.

Effect of Reversal of Neuromuscular Blockade with Sugammadex versus Usual Care on Bleeding Risk in a Randomized Study of Surgical Patients

H. Fennema, A. Szegedi, M. Blobner, 2014, Anesthesiology.

Original and new prospect theory: A discussion and empirical differences

H. Fennema, P. Wakker, 1997 .

Meta-analyses of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other antipsychotics.

H. Fennema, A. Szegedi, P. Verweij, 2012, The Journal of clinical psychiatry.

No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters.

H. Fennema, M. Moerland, M. V. van Lierop, 2013, International journal of clinical pharmacology and therapeutics.

Deep Neuromuscular Blockade Improves Laparoscopic Surgical Conditions: A Randomized, Controlled Study

H. Fennema, J. Rosenberg, A. Szegedi, 2017, Advances in Therapy.

What does the HAMD mean?

Peter Lepping, Stefan Leucht, H. Fennema, 2013, Journal of affective disorders.

Measuring respiratory syncytial virus infection severity in hospitalized children using the Pediatric Respiratory Syncytial Virus Electronic Severity and Outcome Rating System (PRESORS)

H. Fennema, D. Heerwegh, W. Van der Elst, 2022, Influenza and other respiratory viruses.

Measuring the Utility of Losses by Means of the Tradeoff Method

H. Fennema, M. V. van Assen, 1998 .

An explanation and characterization for the buying of lotteries

H. Fennema, P. Wakker, 1994 .

Original and cumulative prospect theory: a discussion of empirical differences

H. Fennema, P. Wakker, 1997 .

Translating the HAM-D into the MADRS and vice versa with equipercentile linking.

H. Fennema, S. Leucht, A. Szegedi, 2018, Journal of affective disorders.

Decision making with transformed probabilities

H. Fennema, 2000 .

What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies.

H. Fennema, S. Leucht, A. Szegedi, 2017, Journal of affective disorders.

Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study

H. Fennema, J. Symons, P. van Remoortere, 2018, The Journal of infectious diseases.

Validation of the controlled ovarian stimulation impact measure (COSI): assessing the patient perspective

H. Fennema, M. Brod, 2013, Health and Quality of Life Outcomes.